Quentin Wilmouth Dieu

Quentin Wilmouth Dieu is a skilled pharmacovigilance professional with extensive experience in global safety assessment for rare diseases. Currently serving as a Pharmacovigilance Officer at Recordati Rare Diseases since September 2022, responsibilities include the redaction of periodic safety reports and implementation of risk minimisation measures. Previous roles encompass Global Vigilance Evaluation Officer at Septodont and Pharmacovigilance Officer at Servier, where key activities involved clinical trial case management and safety document oversight. Earlier experience includes positions at Calypse Consulting, DBV Technologies, and ANSM, specializing in pharmacovigilance and toxicology. Academic credentials include a Doctorate in Pharmacy and a Master's degree in Human Toxicology from Paris-Sud University.